Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)

R. Descourt, M. Pérol, G. Rousseau-Bussac, David Planchard, B. Mennecier, Marie Wislez, Alexis B. Cortot, Florian Guisier, Loïck Galland, Pascal Dô,

Lung Cancer · 2019 · 28 citations · 19 references

DOIFull text

Open access

Concepts

References

19